Literature DB >> 16344499

Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.

J Capkova1, P Ivanyi, Z Rehakova.   

Abstract

BACKGROUND: Ankylosing enthesopathy (ANKENT) with progressive stiffening of ankle and tarsal joints of the hind limbs is a naturally occurring arthropathy in B10.BR mice. Some features are similar to those of the spondyloarthropathies in humans.
OBJECTIVE: To study the role of sexual dimorphism and testosterone in the development of ANKENT.
METHODS: The incidence of ANKENT was observed in non-castrated, castrated, and testosterone substituted castrated male mice, and in control and testosterone treated female mice.
RESULTS: ANKENT occurred only in males; it did not develop in males castrated at age 2-3 months but occurred in castrated males injected with testosterone. Females injected with testosterone did not develop ANKENT.
CONCLUSION: Testosterone can replace what castration eliminates, at least in the postpubertally castrated males, but is itself not sufficient to induce joint disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16344499      PMCID: PMC1797974          DOI: 10.1136/ard.2005.039800

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

Review 1.  No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis.

Authors:  R H Straub; S Struhárová; J Schölmerich; P Härle
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

Review 2.  Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis.

Authors:  Maurizio Cutolo; Bruno Seriolo; Barbara Villaggio; Carmen Pizzorni; Chiara Craviotto; Alberto Sulli
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 3.  B27+ disease versus B27- disease.

Authors:  A Linssen
Journal:  Scand J Rheumatol Suppl       Date:  1990

4.  Introduction: B27-associated diseases.

Authors:  D A Brewerton
Journal:  Scand J Rheumatol Suppl       Date:  1990

5.  Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease.

Authors:  Z Reháková; J Capková; R Stĕpánková; J Sinkora; A Louzecká; P Ivanyi; S Weinreich
Journal:  Hum Immunol       Date:  2000-06       Impact factor: 2.850

6.  Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway.

Authors:  J T Gran; G Husby; M Hordvik
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

7.  Follow-up study of ankylosing spondylitis over a period of 12 years (1977-1989).

Authors:  A J Dekker-Saeys; A C Keat
Journal:  Scand J Rheumatol Suppl       Date:  1990

Review 8.  Androgens and ankylosing spondylitis: a role in the pathogenesis?

Authors:  E J Giltay; D van Schaardenburg; L J Gooren; C Popp-Snijders; B A Dijkmans
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

9.  H-2 influence on ankylosing enthesopathy of the ankle (ANKENT).

Authors:  J Capková; P Ivanyi
Journal:  Folia Biol (Praha)       Date:  1992       Impact factor: 0.906

Review 10.  Perspectives on the relationship of adrenal steroids to rheumatoid arthritis.

Authors:  Alfonse T Masi; Robert T Chatterton; Jean C Aldag; Raymond L Malamet
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

View more
  2 in total

1.  Exogenous testosterone, finasteride and castration effects on testosterone, insulin, zinc and chromium in adult male rats.

Authors:  Namdar Yousofvand; Fatemeh Zarei; Ali Ghanbari
Journal:  Iran Biomed J       Date:  2013

2.  Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: the potential role of interleukin-10.

Authors:  Jana Capkova; Tomas Hrncir; Alena Kubatova; Helena Tlaskalova-Hogenova
Journal:  BMC Musculoskelet Disord       Date:  2012-06-21       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.